Search results for : nab - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Search Results for: nab

Genetic Features (45)

Feature Name	Feature Type
cnaBLCA15	copy number alteration (gain)
cnaBLCA18	copy number alteration (loss)
cnaBLCA23	copy number alteration (gain)
cnaBLCA5	copy number alteration (loss)
cnaBLCA9	copy number alteration (gain)
cnaBRCA10	copy number alteration (gain)
cnaBRCA12	copy number alteration (gain)
cnaBRCA13	copy number alteration (gain)
cnaBRCA14	copy number alteration (gain)
cnaBRCA15	copy number alteration (gain)
cnaBRCA16	copy number alteration (gain)
cnaBRCA17	copy number alteration (loss)
cnaBRCA18	copy number alteration (loss)
cnaBRCA19	copy number alteration (gain)
cnaBRCA20	copy number alteration (loss)
cnaBRCA22	copy number alteration (loss)
cnaBRCA23	copy number alteration (loss)
cnaBRCA24	copy number alteration (loss)
cnaBRCA25	copy number alteration (loss)
cnaBRCA26	copy number alteration (gain)
cnaBRCA27	copy number alteration (gain)
cnaBRCA28	copy number alteration (loss)
cnaBRCA29	copy number alteration (loss)
cnaBRCA30	copy number alteration (gain)
cnaBRCA31	copy number alteration (gain)
cnaBRCA32	copy number alteration (loss)
cnaBRCA33	copy number alteration (loss)
cnaBRCA34	copy number alteration (loss)
cnaBRCA36	copy number alteration (loss)
cnaBRCA38	copy number alteration (loss)
cnaBRCA39	copy number alteration (gain)
cnaBRCA42	copy number alteration (loss)
cnaBRCA47	copy number alteration (gain)
cnaBRCA48	copy number alteration (gain)
cnaBRCA5	copy number alteration (gain)
cnaBRCA57	copy number alteration (loss)
cnaBRCA58	copy number alteration (gain)
cnaBRCA60	copy number alteration (loss)
cnaBRCA61	copy number alteration (gain)
cnaBRCA62	copy number alteration (gain)
cnaBRCA63	copy number alteration (gain)
cnaBRCA64	copy number alteration (gain)
cnaBRCA7	copy number alteration (loss)
cnaBRCA8	copy number alteration (gain)
cnaBRCA9	copy number alteration (gain)

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).